在口腔癌中免疫反应的图书统计分析
Rongrong Zhang1,2,3, Runying Guo1,2,3, Yuqi Xin1,2,3
1Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Discover oncology
|February 10, 2025
概括
这项研究分析了从2003年到2023年口腔状细胞癌 (OSCC) 免疫学研究的趋势. 研究结果强调新辅助免疫疗法,包括尼沃卢马布和化疗,是未来OSCC治疗开发的关键领域.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 口腔状细胞癌 (OSCC) 带来了重大的死亡率挑战.
- 在OSCC中的瘤微环境 (TME) 是复杂的,重点是免疫反应.
- 现有的研究缺乏OSCC免疫学方面的全面趋势分析.
研究的目的:
- 进行OSCC免疫学研究趋势的文献分析.
- 从2003年到2023年,绘制OSCC免疫学研究的演变图.
主要方法:
- 在科学网络核心集合 (2003-2023) 上进行了全面的文献搜索.
- 通过使用VOSviewer,Citespace,Scimago Graphica和R软件进行了图书统计分析.
主要成果:
- 确定了805个出版物,其中中国和美国的重要贡献.
- 弗里德曼·杰伊是最常被引用的作者",口腔瘤学"是主要的期刊.
- 关键词爆发分析显示,人们对尼沃卢马布和化疗有很大的兴趣,这表明新辅助免疫疗法是有前途的方向.
结论:
- 这项研究提供了有关OSCC免疫学当前趋势和研究前沿的有价值的概述.
- 这些发现为未来的研究和OSCC治疗的治疗策略提供了新的见解.
更多相关视频
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.6K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cytotoxic T Cells-mediated Immune Response
832
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
832
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
